Cost Of Revenue - Novogene Co Ltd (SSE:688315) - Alpha Spread

Novogene Co Ltd
SSE:688315

Watchlist Manager
Novogene Co Ltd Logo
Novogene Co Ltd
SSE:688315
Watchlist
Price: 9.45 CNY -3.67% Market Closed
Market Cap: 3.9B CNY
Have any thoughts about
Novogene Co Ltd?
Write Note

Novogene Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Novogene Co Ltd
Cost of Revenue Peer Comparison

Comparables:
603259
300759
2269
300347
1548

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Novogene Co Ltd
SSE:688315
Cost of Revenue
-ÂĄ1.1B
CAGR 3-Years
-6%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Cost of Revenue
-ÂĄ23.3B
CAGR 3-Years
-23%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Cost of Revenue
-ÂĄ7.7B
CAGR 3-Years
-25%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Cost of Revenue
-ÂĄ10.5B
CAGR 3-Years
-38%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Cost of Revenue
-ÂĄ4.4B
CAGR 3-Years
-29%
CAGR 5-Years
-24%
CAGR 10-Years
-35%
Genscript Biotech Corp
HKEX:1548
Cost of Revenue
-$468.1m
CAGR 3-Years
-41%
CAGR 5-Years
-41%
CAGR 10-Years
N/A

See Also

What is Novogene Co Ltd's Cost of Revenue?
Cost of Revenue
-1.1B CNY

Based on the financial report for Dec 31, 2023, Novogene Co Ltd's Cost of Revenue amounts to -1.1B CNY.

What is Novogene Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-14%

Over the last year, the Cost of Revenue growth was -7%. The average annual Cost of Revenue growth rates for Novogene Co Ltd have been -6% over the past three years , -14% over the past five years .

Back to Top